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Summary
Background: The annual rate for childhood cancers in developed countries amounts to 105–130 new cases
per 1 million children. The Polish population aged 0–17 years is estimated at approximately
10 million children and adolescents, thus ca. 1100–1300 new cases can be expected every
year. In 1995, we started a national childhood cancer registry.
Material/Methods: Information on the new diagnoses of childhood cancers was collected in 11 regional centers
and submitted to the national center in Lublin. All data were verified carefully and standar-
dized incidence rates were calculated.
Results: In 1995, we registered 1028 newly diagnosed malignant neoplasms, in 1996 and 1997 – 1036
cases, in 1998 – 1007, and in 1999 – 1158 new cases. The estimated incidence rates were:
102.4; 109.5; 111.9; 111.6 and 118.3 per 1 million children, respectively. The most frequent
childhood cancers include leukemia, which accounts for 28% of cancer cases, lymphoma
(14.3%) and C. N. S. tumors (16.3%).
Conclusions: Neoplasms of the hematopoietic system (leukemias and lymphomas) account for about 42% of
all childhood cancers. Malignant lymphomas, bone tumors and germinal tumors are more fre-
quently diagnosed in Poland, but the incidence of central nervous system tumors is lower than
in other countries.
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BACKGROUND
Childhood tumors are very differentiated with respect
to histological types and anatomical locations. According
to the International Classification of Diseases for Oncol-
ogy (ICD-O) and International Classification of Child-
hood Cancers (ICCC) [1,2], 12 main diagnostic groups
of neoplastic diseases are distinguished. The incidence
of these tumors considerably differs from that observed
in adult population. In many countries, analyses of inci-
dence of individual childhood cancers is currently ana-
lyzed on the basis of registers made according to that
classification. In Poland, information concerning child-
hood cancers has been available so far in the National
Register of Neoplasms, elaborated by Maria Sk∏odows-
ka-Curie Oncology Center, based on organ-related clas-
sification of tumors characteristic of adult age [3]. The
system gives rise to some problems associated with
analysis of cancer incidence in the population aged from
0 to 17 years. For that reason, the National Team of
Medical Consultants in pediatric oncology initiated in
1995 an attempt to create a National Register of Child-
hood Cancers, enabling detailed analysis of their inci-
dence according to the ICD-O classification.
MATERIAL AND METHODS
Since 1995, as a part of nationwide surveillance in the
field of pediatric oncology, own registration of all new
cases of neoplastic diseases diagnosed in children in
each calendar year has been kept. All reports of new
cases were collected by Regional Consultants and sub-
mitted to the center in Lublin. Individual entries,
including personal particular of the patients, were then
verified to avoid counting the same patients consulted
or treated in more than one center several times. Addi-
tionally, the diagnoses were verified in co-operation
with individual centers. The obtained raw data illustrat-
ing the morbidity with respect to various types of child-
hood cancers were used to calculate standardized inci-
dence rates per 1 million children, based on standard
world population [4].
RESULTS
In 1995, 1028 newly diagnosed malignant neoplasms
were registered among children from 0 to 17 years of
age, in 1996 and 1997 – 1036 cases, in 1998 – 1007, and
in 1999 – 1158 new cases (Table 1). The estimated stan-
dardized incidence rates, related to standard world pop-
ulation were: 102.4; 109.5; 111.9; 111.6 and 118.3 per 1
million children, respectively. New cases according to
tumor types are presented in Table 2. As it follows from
that table, no significant changes in the numbers of new
cases of particular tumor types were noted during the 5-
year period of registration. However, it can be seen that
lymphomas, bone tumors and germinal tumors are more
frequent in Poland than in other European countries,
whereas CNS tumors occur less frequently (Table 3).
DISCUSSION
The annual rate for childhood cancers in developed
countries amounts to 105–130 new cases per 1 million
children. Thus, in a region inhabited by 50–75 thou-
sand children, 5 to 10 new cases can be expected to
occur every year [5–8]. In some geographical regions,
however, this incidence is higher. It amounts to over
140 new cases per 1 million population in Nigeria, Los
Angeles (white population), Sao Paulo in Brazil, New
Zealand, Sweden and Australia [5,9]. In Poland there
are currently ca. 10 million children aged from 0 to 17
years (Table 4). Based on European data, ca. 1100–1200
new cases a year can be expected. At the same time, the
number of patients undergoing treatment (lasting up to
Leukemias
ALL
ANLL
Lymphomas
NHL
HD
Brain tumors
Sympathetic system tumors
Retinoblastoma
Renal tumors
Hepatic tumors
Bone tumors
Soft tissue tumors
Gonadal and germinal tumors
Epithelial tumors
Others
332
257
58
122
68
54
204
68
21
67
14
82
66
52
7
3
265
212
46
161
79
82
190
67
28
79
17
74
70
54
19
12
310
262
39
152
73
79
156
73
26
63
12
79
69
66
11
20
281
245
28
155
89
66
119
75
34
58
17
100
66
68
17
19
308
248
48
175
83
92
188
72
22
77
16
73
40
89
9
58
Year 1995 1996 1997 1998 1999
Table 2. Incidence of various tumor types among children
and adolescents in Poland in 1995–1999.
Number of cases
Incidence/1 million
1028
102.4
1036
109.5
1036
111.9
1007
111.6
1158
118.3
Year 1995 1996 1997 1998 1999
Table 1. New cases of all malignant tumors in 0–17 age group
in Poland and morbidity rates per 1 million in 1995–1999.
Leukemias
Lymphomas
Brain tumors
Sympathetic system tumors
Retinoblastoma
Renal tumors
Hepatic tumors
Bone tumors
Soft tissue tumors
Gonadal and germinal tumors
Epithelial tumors
Others
28.7%
14.3%
16.3%
6.9%
2.7%
6.5%
1.5%
8.2%
6.6%
5.8%
1.3%
1.3%
33.5%
9.9%
22.6%
6.8%
3.35
6.9%
0.9%
4.2%
6.0%
2.3%
1.8%
0.2%
Tumor group Poland Europe
Table 3. Incidence of various childhood tumors in Poland (according
to data from 1995–1999) and in Europe.
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3 years in some tumor types) or monitored during the
periods of remission until they can be considered as
cured is cumulating. Therefore, it can be assumed that
there are 5 to 6 thousand children who have undergone
treatment for neoplastic diseases in Poland. This num-
ber will increase every year, because the currently used
methods of treatment make it possible to cure most of
these patients.
Leukemias, mainly of acute lymphoblastic type, are
most frequent tumors among Polish children, account-
ing for over 28% of all tumor types. Taken together
with lymphomas (over 14%), tumors of the hematopoi-
etic system account for ca. 42% of all childhood neo-
plasias, similarly as in other countries [5–7,9–14]. Cen-
tral nervous system tumors, accounting for ca. 16% of
all tumor cases, constitute the second most prevalent
cancer group (Table 3).
Various childhood cancers are characterized by differ-
ent incidences in particular age groups. Peak incidence
occurring during the earliest years of life characterizes
embryonic tumors. This is why most cases of neuroblas-
toma, retinoblastoma or hepatoblastoma are diagnosed
during the first year of life [12–15]. The onset of acute
lymphoblastic leukemia occurs most frequently between
2 and 4 years of age. Adolescence is the age associated
with the highest incidence of Hodgkin’s disease,
osteosarcoma and Ewing sarcoma [12–18]. In the case of
fibromyoma, two periods of peak incidence are
observed: the first one in infancy, and the second one
between 10 and 14 years of age. Similar distribution is
observed with respect to germinal gonadal tumors. In
boys, they are most often diagnosed in early childhood,
then the incidence falls rapidly to increase again before
15 years of age and remain at higher level until the end
of the pubescence period. In girls, on the other hand,
such tumors are uncommon in early childhood and
their incidence increases during the pubescence period
[14,15]. The incidence of childhood cancers is generally
slightly higher among males than among females with
the ratio of 4:3. The predominance of male patients is
the highest with respect to lymphomas, less marked
with respect to leukemias, brain tumors, neuroblastoma,
osteosarcoma and soft tissue sarcomas. Wilms tumors
and retinoblastoma occur in both sexes with the same
incidence. Girls suffer more frequently from germinal
tumors, adrenal cortex and thyroid gland carcinomas
[6,8,14,15].
Continuation of analysis of new childhood cancer cases
will allow to observe changes in the incidence of particu-
lar tumor types [19]. Compliance of the system with
classification typical of childhood cancers will allow to
compare the data with those obtained in other coun-
tries.
CONCLUSIONS
1. In Poland the annual number of new cases of malig-
nant tumors ranges from 102 to 118 per 1 million
children and adolescents below the age of 18.
2. The most common childhood cancers are neoplasias
of the hematopoietic system – leukemias and lym-
phomas, accounting for ca. 42% of all cancers diag-
nosed in this age group.
3. Malignant lymphomas, bone tumors and germinal
tumors are more frequent in Poland than in other
European countries, whereas CNS tumors occur less
frequently.
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